MARATHON ASSET MANAGEMENT LLP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
MARATHON ASSET MANAGEMENT LLP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2021$45,980,000
+1.9%
543,663
-3.0%
0.64%
+0.9%
Q4 2020$45,120,000
-3.9%
560,672
-3.6%
0.63%
-14.1%
Q3 2020$46,930,000
-17.1%
581,673
-11.3%
0.74%
-15.0%
Q2 2020$56,628,000
-14.9%
655,577
-19.8%
0.87%
-27.2%
Q1 2020$66,519,000
-7.4%
817,285
-4.7%
1.19%
+26.2%
Q4 2019$71,855,000
+36.7%
857,219
+43.0%
0.94%
+36.8%
Q3 2019$52,568,000
+0.9%
599,467
-5.5%
0.69%
+3.3%
Q2 2019$52,096,000
+2.8%
634,464
+2.0%
0.67%
-1.0%
Q1 2019$50,695,000
+27.4%
622,065
+3.2%
0.68%
+15.0%
Q4 2018$39,794,000
-8.9%
603,048
+6.7%
0.59%
+6.5%
Q3 2018$43,661,000
+1.9%
565,050
-2.4%
0.55%
-13.8%
Q2 2018$42,865,000
+14.0%
579,125
+0.4%
0.64%
+10.2%
Q1 2018$37,613,000
+4.5%
576,987
+3.9%
0.58%
+4.9%
Q4 2017$35,983,000
-67.1%
555,385
-7.0%
0.55%
-69.2%
Q3 2017$109,461,000
+79.6%
597,163
-40.5%
1.80%
+70.4%
Q2 2017$60,951,000
+42.3%
1,004,378
+21.9%
1.06%
+12.6%
Q1 2017$42,823,000
+13.2%
823,872
-3.1%
0.94%
+14.8%
Q4 2016$37,814,000
+3.5%
850,456
-23.3%
0.82%
-7.3%
Q3 2015$36,518,000
-52.9%
1,108,253
+0.5%
0.88%
-50.3%
Q2 2015$77,552,000
-0.5%
1,102,348
-2.4%
1.77%
-6.0%
Q1 2015$77,907,000
-7.6%
1,129,679
-1.2%
1.88%
-6.9%
Q4 2014$84,322,000
+1.8%
1,143,106
-0.4%
2.02%
-0.1%
Q3 2014$82,838,000
+18.3%
1,148,243
+21.4%
2.03%
+12.9%
Q1 2014$70,051,000946,1091.80%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders